Literature DB >> 24842598

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.

.   

Abstract

BACKGROUND: High blood pressure, blood glucose, serum cholesterol, and BMI are risk factors for cardiovascular diseases and some of these factors also increase the risk of chronic kidney disease and diabetes. We estimated mortality from cardiovascular diseases, chronic kidney disease, and diabetes that was attributable to these four cardiometabolic risk factors for all countries and regions from 1980 to 2010.
METHODS: We used data for exposure to risk factors by country, age group, and sex from pooled analyses of population-based health surveys. We obtained relative risks for the effects of risk factors on cause-specific mortality from meta-analyses of large prospective studies. We calculated the population attributable fractions for each risk factor alone, and for the combination of all risk factors, accounting for multicausality and for mediation of the effects of BMI by the other three risks. We calculated attributable deaths by multiplying the cause-specific population attributable fractions by the number of disease-specific deaths. We obtained cause-specific mortality from the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study. We propagated the uncertainties of all the inputs to the final estimates.
FINDINGS: In 2010, high blood pressure was the leading risk factor for deaths due to cardiovascular diseases, chronic kidney disease, and diabetes in every region, causing more than 40% of worldwide deaths from these diseases; high BMI and glucose were each responsible for about 15% of deaths, and high cholesterol for more than 10%. After accounting for multicausality, 63% (10·8 million deaths, 95% CI 10·1-11·5) of deaths from these diseases in 2010 were attributable to the combined effect of these four metabolic risk factors, compared with 67% (7·1 million deaths, 6·6-7·6) in 1980. The mortality burden of high BMI and glucose nearly doubled from 1980 to 2010. At the country level, age-standardised death rates from these diseases attributable to the combined effects of these four risk factors surpassed 925 deaths per 100 000 for men in Belarus, Kazakhstan, and Mongolia, but were less than 130 deaths per 100 000 for women and less than 200 for men in some high-income countries including Australia, Canada, France, Japan, the Netherlands, Singapore, South Korea, and Spain.
INTERPRETATION: The salient features of the cardiometabolic disease and risk factor epidemic at the beginning of the 21st century are high blood pressure and an increasing effect of obesity and diabetes. The mortality burden of cardiometabolic risk factors has shifted from high-income to low-income and middle-income countries. Lowering cardiometabolic risks through dietary, behavioural, and pharmacological interventions should be a part of the global response to non-communicable diseases. FUNDING: UK Medical Research Council, US National Institutes of Health.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24842598      PMCID: PMC4572741          DOI: 10.1016/S2213-8587(14)70102-0

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  57 in total

1.  Estimates of global and regional potential health gains from reducing multiple major risk factors.

Authors:  Majid Ezzati; Stephen Vander Hoorn; Anthony Rodgers; Alan D Lopez; Colin D Mathers; Christopher J L Murray
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

2.  Behavioral and dietary risk factors for noncommunicable diseases.

Authors:  Majid Ezzati; Elio Riboli
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

3.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

4.  Changing the future of obesity: science, policy, and action.

Authors:  Steven L Gortmaker; Boyd A Swinburn; David Levy; Rob Carter; Patricia L Mabry; Diane T Finegood; Terry Huang; Tim Marsh; Marjory L Moodie
Journal:  Lancet       Date:  2011-08-27       Impact factor: 79.321

5.  Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Authors:  F M Turnbull; C Abraira; R J Anderson; R P Byington; J P Chalmers; W C Duckworth; G W Evans; H C Gerstein; R R Holman; T E Moritz; B C Neal; T Ninomiya; A A Patel; S K Paul; F Travert; M Woodward
Journal:  Diabetologia       Date:  2009-08-05       Impact factor: 10.122

6.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; John K Lin; Gitanjali M Singh; Christopher J Paciorek; Melanie J Cowan; Farshad Farzadfar; Gretchen A Stevens; Stephen S Lim; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

Review 7.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

8.  Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment.

Authors:  Nayu Ikeda; Manami Inoue; Hiroyasu Iso; Shunya Ikeda; Toshihiko Satoh; Mitsuhiko Noda; Tetsuya Mizoue; Hironori Imano; Eiko Saito; Kota Katanoda; Tomotaka Sobue; Shoichiro Tsugane; Mohsen Naghavi; Majid Ezzati; Kenji Shibuya
Journal:  PLoS Med       Date:  2012-01-24       Impact factor: 11.069

9.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.

Authors:  Gary Whitlock; Sarah Lewington; Paul Sherliker; Robert Clarke; Jonathan Emberson; Jim Halsey; Nawab Qizilbash; Rory Collins; Richard Peto
Journal:  Lancet       Date:  2009-03-18       Impact factor: 79.321

Review 10.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

View more
  227 in total

Review 1.  Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies.

Authors:  K Hidayat; X Du; B-M Shi
Journal:  Osteoporos Int       Date:  2019-05-27       Impact factor: 4.507

Review 2.  The role of home BP monitoring: Answers to 10 common questions.

Authors:  Sonal J Patil; Richelle J Koopman; Jeffery Belden; Michael LeFevre
Journal:  J Fam Pract       Date:  2019 Jan/Feb       Impact factor: 0.493

3.  Put pressure worldwide on blood pressure control.

Authors:  Simona Costanzo; Giovanni de Gaetano; Licia Iacoviello
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

4.  The new 2017 ACC/AHA guideline for classification of hypertension: changes in prevalence of hypertension among adults in Bangladesh.

Authors:  Gulam Muhammed Al Kibria; Krystal Swasey; Allysha Choudhury; Vanessa Burrowes; Kristen A Stafford; S M Iftekhar Uddin; Mohammadhassan Mirbolouk; Atia Sharmeen; Angela Kc; Dipak K Mitra
Journal:  J Hum Hypertens       Date:  2018-06-13       Impact factor: 3.012

5.  Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance.

Authors:  Keiji Tanigaki; Anastasia Sacharidou; Jun Peng; Ken L Chambliss; Ivan S Yuhanna; Debabrata Ghosh; Mohamed Ahmed; Alexander J Szalai; Wanpen Vongpatanasin; Robert F Mattrey; Qiushi Chen; Parastoo Azadi; Ildiko Lingvay; Marina Botto; William L Holland; Jennifer J Kohler; Shashank R Sirsi; Kenneth Hoyt; Philip W Shaul; Chieko Mineo
Journal:  J Clin Invest       Date:  2017-11-27       Impact factor: 14.808

6.  Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Authors:  Stephen Zewinger; Thomas Rauen; Michael Rudnicki; Giuseppina Federico; Martina Wagner; Sarah Triem; Stefan J Schunk; Ioannis Petrakis; David Schmit; Stefan Wagenpfeil; Gunnar H Heine; Gert Mayer; Jürgen Floege; Danilo Fliser; Hermann-Josef Gröne; Thimoteus Speer
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

Review 7.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.

Authors:  Julia A Critchley; Blanca I Restrepo; Katharina Ronacher; Anil Kapur; Andrew A Bremer; Larry S Schlesinger; Randall Basaraba; Hardy Kornfeld; Reinout van Crevel
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

8.  Super-Resolution Ultrasound Imaging of Skeletal Muscle Microvascular Dysfunction in an Animal Model of Type 2 Diabetes.

Authors:  Debabrata Ghosh; Jun Peng; Katherine Brown; Shashank Sirsi; Chieko Mineo; Philip W Shaul; Kenneth Hoyt
Journal:  J Ultrasound Med       Date:  2019-01-31       Impact factor: 2.153

9.  Effectiveness of Self-Monitoring Blood Pressure in Primary Care: A Randomized Controlled Trial.

Authors:  Wichai Aekplakorn; Paibul Suriyawongpaisal; Rassamee Tansirisithikul; Thida Sakulpipat; Phikul Charoensuk
Journal:  J Prim Care Community Health       Date:  2015-11-16

Review 10.  Cardiovascular Risk Factors After Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S): a New Effective Therapeutic Approach?

Authors:  Antonio Torres; Miguel A Rubio; Ana M Ramos-Leví; Andrés Sánchez-Pernaute
Journal:  Curr Atheroscler Rep       Date:  2017-11-07       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.